Radi, ne radi, radi, ne radi, ne radi: Oprečni rezultati dve studije o remdesiviru

Wide scale testing is a critical part of tracking and containing infectious diseases. But the U.S. effort has been plagued by a series of missteps, including accuracy problems with the test kits the CDC sent to other labs and bureaucratic hurdles that slowed the entrance of large, private sector labs. (AP Photo/John Minchillo) Američka laboratorija Gilead objavila je danas da je njen lek remdesivir pokazao “pozitivne” rezultate kod obolelih od Kovida-19 u velikom